Equillium, Inc. (EQ)
NASDAQ: EQ · Real-Time Price · USD
0.880
-0.004 (-0.49%)
At close: Feb 21, 2025, 4:00 PM
0.870
-0.010 (-1.14%)
After-hours: Feb 21, 2025, 5:31 PM EST
Equillium Employees
Equillium had 44 employees as of December 31, 2023. The number of employees increased by 8 or 22.22% compared to the previous year.
Employees
44
Change (1Y)
8
Growth (1Y)
22.22%
Revenue / Employee
$1,043,500
Profits / Employee
-$104,886
Market Cap
31.18M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
EQ News
- 16 days ago - Equillium Announces Positive Data from Phase 2 Study Evaluating Itolizumab in Patients with Moderate to Severe Ulcerative Colitis - Business Wire
- 3 months ago - Equillium Reports Third Quarter 2024 Financial Results and Provides Corporate and Clinical Updates - Business Wire
- 3 months ago - Equillium to Present at the Stifel Healthcare Conference - Business Wire
- 3 months ago - Equillium Announces Poster Presentation at the Society for Immunotherapy of Cancer - Business Wire
- 4 months ago - Equillium Maintains Rights to Itolizumab Following Ono Partnership - Business Wire
- 4 months ago - Equillium Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer - Business Wire
- 5 months ago - Equillium to Present at the Stifel Virtual Inflammation & Immunology Summit - Business Wire
- 6 months ago - Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Business Wire